The "Dendreonians" have probably already seen it, but I wanted to call your attention to a pretty long piece that ran in the health section of the Los Angeles Times on Dec. 31st. It's about the grass-roots movement to get Dendreon's prostate cancer drug, Provenge, approved by the FDA. Here's the link.
There's not much new in the piece, but it is a high-profile story in one of the nation's biggest newspapers and could add more fuel to the fire. What you can't see in the online version is the headline on the jump page (that's the continuation of a newspaper story on another page) of the hard copy which reads, "FDA leaves end-stage prostate cancer drug in limbo."
Right now we are waiting to hear from the House Energy & Commerce Committee regarding whether it will launch an investigation and/or hold a hearing into the Provenge saga. A spokesman for the committee says I'll get an email as soon as a formal decision is announced.
I happened to catch the Dendreon article because I'm in L.A. for the Rose Bowl where the mighty USC Trojans--as I predicted in this blog last week--trounced the Fighting Illini. While 'SC put on a great show in the 49-17 win, I thought the best play was the razzle-dazzler that led to Desmond Reed's somersault into the end zone.